Metastatic Tumor: Clinical Trials

15 trials for Metastatic Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 3 unknown, 2 active not recruiting. 15 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 115Completed 4, Recruiting 3, Unknown 3, Active not recruiting 2, Terminated 2, Not yet recruiting 1
Phase 22Active not recruiting 1, Terminated 1

Follow Metastatic Tumor: new trials by email Literature Review of Metastatic Tumor trials Research Report on Metastatic Tumor

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
5 Azacytidine, Pembrolizumab, Nivolumab - Solid Tumor, Locally Advanced Solid Tumor
Phase 1RecruitingMohammed Milhem352026-02-112026-05-28
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NKT3964, Paclitaxel, Doxorubicin - Solid Tumor, Advanced Solid Tumor
Phase 1RecruitingNiKang Therapeutics, Inc.2382024-09-192026-11-05
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
CHT101 - Metastatic Tumor, Advanced Solid Tumor
Phase 1Not yet recruitingZhejiang University182024-04-222024-04-25
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
NKT3447 - Solid Tumor, Solid Tumor, Adult
Phase 1TerminatedNiKang Therapeutics, Inc.232024-02-232025-09-25
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
AZD1390, Stereotactic Body Radiotherapy - Solid Tumor, Metastatic Solid Tumor
Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center542023-05-172026-05-18
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
TST003 - Locally Advanced Solid Tumor, Metastatic Tumor
Phase 1 / Phase 2Active not recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.1112023-02-082026-09-29
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
CD70 CAR-T cells - Metastatic Tumor, Advanced Solid Tumor
Phase 1UnknownChongqing Precision Biotech Co., Ltd482022-07-172023-08-18
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
CD70 CAR-T cells - Metastatic Tumor, Advanced Solid Tumor
Phase 1RecruitingWeijia Fang, MD302022-05-302025-05-31
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
CD70 CAR-T cells - Metastatic Tumor, Renal Cell Carcinoma
Phase 1UnknownChongqing Precision Biotech Co., Ltd242021-12-312023-08-18
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
CD70 CAR-T cells - Metastatic Tumor, Advanced Solid Tumor
Phase 1UnknownChongqing Precision Biotech Co., Ltd362021-12-312023-08-18
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
AFM24, SNK01 - Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2TerminatedNKGen Biotech, Inc.112021-11-032024-03-01
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
CEA CAR-T cells - Colorectal Cancer, Esophageal Cancer
Phase 1CompletedChongqing Precision Biotech Co., Ltd302021-09-102026-07-09
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors
Axatilimab, Durvalumab - Solid Tumor, Metastatic Tumor
Phase 1CompletedSyndax Pharmaceuticals452017-09-012024-05-17
Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.
Pexa-Vec, Ipilimumab - Metastatic Tumor, Advanced Tumor
Phase 1CompletedCentre Leon Berard222017-01-032022-07-25
A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread
LY2334737 - Malignant Solid Tumor, Solid Tumor
Phase 1CompletedEli Lilly and Company732008-09-012019-06-17

Narrower conditions

Neoplasm Metastasis (15)  ·  Ovarian Neoplasms (6)  ·  Carcinoma, Renal Cell (5)  ·  Uterine Cervical Neoplasms (4)  ·  Stomach Neoplasms (3)  ·  Colorectal Neoplasms (2)  ·  Endometrial Neoplasms (2)  ·  Small Cell Lung Carcinoma (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Triple Negative Breast Neoplasms (2)  ·  Uterine Diseases (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)

Broader conditions

Neoplastic Processes (15)  ·  Pathologic Processes (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Neoplasms (14)  ·  Neoplasms by Site (9)  ·  Endocrine Gland Neoplasms (7)  ·  Endocrine System Diseases (7)  ·  Female Urogenital Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Urogenital Diseases (7)  ·  Urogenital Neoplasms (7)  ·  Adnexal Diseases (6)  ·  Carcinoma (6)  ·  Genital Diseases (6)  ·  Genital Diseases, Female (6)

Interventions

AZD1390 (1)  ·  Azacitidine (1)  ·  Doxorubicin (1)  ·  Ipilimumab (1)  ·  LY2334737 (1)  ·  Nivolumab (1)  ·  Paclitaxel (1)  ·  Radiosurgery (1)  ·  axatilimab (1)  ·  cemiplimab (1)  ·  durvalumab (1)  ·  pembrolizumab (1)

Sponsors

Chongqing Precision Biotech Co., Ltd (4)  ·  NiKang Therapeutics, Inc. (2)  ·  Centre Leon Berard (1)  ·  Eli Lilly and Company (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Mohammed Milhem (1)  ·  NKGen Biotech, Inc. (1)  ·  Syndax Pharmaceuticals (1)  ·  Transcenta Therapeutics (Hangzhou) Co., Ltd. (1)  ·  Weijia Fang, MD (1)  ·  Zhejiang University (1)

Countries

United States (8)  ·  China (5)  ·  France (2)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Jianfeng Bi, M.D (2)  ·  Daniel Higginson, MD (1)  ·  Jingwang Bi, M.D (1)  ·  Kate Madigan, MD (1)  ·  Mohammed Milhem, MD (1)  ·  Paul Chang, MPH (1)  ·  Quanli Gao, M.D (1)  ·  Weijia Fang, M.D (1)

Results publications

PMID 39704205

NIH funding

2008 (1)